影像组学在非小细胞肺癌诊疗中的应用进展

doi:10.11904/j.issn.1002-3070.2021.05.019

摘要/Abstract

摘要： 影像组学作为一种新兴技术,能够用以检出结节,区分良恶性病变,甚至预测病灶组织学分期以及基因型。当其被应用于非小细胞肺癌治疗中时,可以提高疗效评估准确率以及预测复发风险。影像组学有望越来越多地影响非小细胞肺癌的临床治疗实践,优化端到端的诊疗随访链条,本文现对非小细胞肺癌影像组学最新研究现状做一综述。

关键词: 非小细胞肺癌, 影像组学, 定量成像, 放射性生物标记物

Abstract: As an emerging new technology,radiomics can be used to detect nodules,distinguish benign and malignant lesions,and even predict the histological stage and genotype of lesions.When it is applied to the treatment of non-small cell lung cancer,it can improve the accuracy of efficacy assessment and predict the risk of recurrence.Radiomics is expected to increasingly influence the clinical treatment practice of non-small cell lung cancer,and optimize the follow-up chain of end-to-end diagnosis and treatment.This article reviews the latest research status of radiomics for non-small cell lung cancer.

Key words: Non-small cell lung cancer, Radiomics, Quantitative imaging, Radioactive biomarkers

中图分类号:

R734

汪叶, 尚乃舰. 影像组学在非小细胞肺癌诊疗中的应用进展[J]. 实用肿瘤学杂志, 2021, 35(5): 485-488.

WANG Ye, SHANG Naijian. Application progress of radiomics in the diagnosis and treatment of non-small cell lung cancer[J]. Journal of Practical Oncology, 2021, 35(5): 485-488.

0
/ / 推荐

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/10.11904/j.issn.1002-3070.2021.05.019

http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/Y2021/V35/I5/485

参考文献

1 Siegel RL,Miller KD,Jemal A.Cancer statistics,2020[J].CA Cancer J Clin,2020,70(1):7-30.
2 Bade BC,Dela Cruz CS.Lung cancer 2020:epidemiology,etiology,and prevention[J].Clin Chest Med,2020,41(1):1-24.
3 Castiglioni I,Gallivanone F,Soda P,et al.AI-based applications in hybrid imaging:how to build smart and truly multi-parametric decision models for radiomics[J].Eur J Nucl Med Mol Imaging,2019,46(13):2673-2699.
4 李双双,侯震,刘娟,等.影像组学分析与建模工具综述[J].中国医学物理学杂志,2018,35(9):1043-1049.
5 Ma J,Qian W,Ren Y,et al.Automatic lung nodule classification with radiomics approach[C].SPIE Medical Imaging.Medical Imaging 2016:PACS and Imaging Informatics:Next Generation and Innovations,2016.
6 Traverso A,Wee L,Dekker A,et al.Repeatability and reproducibility of radiomic features:A Systematic Review[J].Int J Radiat Oncol Biol Phys,2018,102(4):1143-1158.
7 Hassani C,Varghese BA,Nieva J,et al.Radiomics in pulmonary lesion imaging[J].AJR Am J Roentgenol,2019,212(3):497-504.
8 Zhang T,Yuan M,Zhong Y,et al.Differentiation of focal organising pneumonia and peripheral adenocarcinoma in solid lung lesions using thin-section CT-based radiomics[J].Clin Radiol,2019,74(1):23-78.
9 Beig N,Khorrami M,Alilou M,et al.Perinodular and intranodular radiomic features on lung ct images distinguish adenocarcinomas from granulomas[J].Radiology,2019,290(3):783-792.
10 Balagurunathan Y,Schabath MB,Wang H,et al.Quantitative imaging features improve discrimination of malignancy in pulmonary nodules[J].Sci Rep,2019,9(1):8528.
11 Petkovska I,Shah SK,Mcnitt-Gray MF,et al.Pulmonary nodule characterization:a comparison of conventional with quantitative and visual semi-quantitative analyses using contrast enhancement maps[J].Eur J Radiol,2006,59(2):244-252.
12 Chen C,Chang C,Tu C,et al.Radiomic features analysis in computed tomography images of lung nodule classification[J].PLoS One,2018,13(2):e192002.
13 Zhang L,Chen B,Liu X,et al.Quantitative biomarkers for prediction of epidermal growth factor receptor mutation in non-small cell lung cancer[J].Transl Oncol,2018,11(1):94-101.
14 Liu Y,Kim J,Balagurunathan Y,et al.Radiomic features are associated with egfr mutation status in lung adenocarcinomas[J].Clin Lung Cancer,2016,17(5):441-448.
15 Tu W,Sun G,Fan L,et al.Radiomics signature:a potential and incremental predictor for EGFR mutation status in NSCLC patients,comparison with CT morphology[J].Lung Cancer,2019,132:28-35.
16 Li S,Ding C,Zhang H,et al.Radiomics for the prediction of EGFR mutation subtypes in non‐small cell lung cancer[J].Med Phys,2019,46(10):4545-4552.
17 Li H,Zhang R,Wang S,et al.CT-Based radiomic signature as a prognostic factor in stage IV ALK-positive non-small-cell lung cancer treated with TKI crizotinib:a proof-of-concept study[J].Front Oncol,2020,10:57.
18 Song L,Zhu Z,Mao L,et al.Clinical,conventional ct and radiomic feature-based machine learning models for predicting alk rearrangement status in lung adenocarcinoma patients[J].Front Oncol,2020,10:369.
19 Coroller TP,Agrawal V,Narayan V,et al.Radiomic phenotype features predict pathological response in non-small cell lung cancer[J].Radiother Oncol,2016,119(3):480-486.
20 孙明亮,徐建宇.早期非小细胞肺癌立体定向放疗的相关研究[J].实用肿瘤学杂志,2018,32(1):53-56.
21 Lafata KJ,Hong JC,Geng R,et al.Association of pre-treatment radiomic features with lung cancer recurrence following stereotactic body radiation therapy[J].Phys Med Biol,2019,64(2):25007.
22 Coroller TP,Agrawal V,Huynh E,et al.Radiomic-based pathological response prediction from primary tumors and lymph nodes in NSCLC[J].J Thorac Oncol,2017,12(3):467-476.
23 Jiang M,Sun D,Guo Y,et al.Assessing PD-L1 expression level by radiomic features from pet/ct in nonsmall cell lung cancer patients:an initial result[J].Acad Radiol,2020,27(2):171-179.
24 Ramella S,Fiore M,Greco C,et al.A radiomic approach for adaptive radiotherapy in non-small cell lung cancer patients[J].PLoS One,2018,13(11):e207455.
25 Bousabarah K,Temming S,Hoevels M,et al.Radiomic analysis of planning computed tomograms for predicting radiation-induced lung injury and outcome in lung cancer patients treated with robotic stereotactic body radiation therapy[J].Strahlenther Onkol,2019,195(9):830-842.
26 Huang L,Chen J,Hu W,et al.Assessment of a radiomic signature developed in a general NSCLC cohort for predicting overall survival of ALK-positive patients with different treatment types[J].Clin Lung Cancer,2019,20(6):638-651.
27 Mattonen SA,Palma DA,Haasbeek CJ,et al.Early prediction of tumor recurrence based on CT texture changes after stereotactic ablative radiotherapy(SABR)for lung cancer[J].Med Phys,2014,41(3):33502.
28 Mattonen SA,Palma DA,Johnson C,et al.Detection of local cancer recurrence after stereotactic ablative radiation therapy for lung cancer:physician performance versus radiomic assessment[J].Int J Radiat Oncol Biol Phys,2016,94(5):1121-1128.
29 Fried DV,Mawlawi O,Zhang L,et al.Stage III Non-Small cell lung cancer:prognostic value of FDG PET quantitative imaging features combined with clinical prognostic factors[J].Radiology,2016,278(1):214-222.
30 van Velden FH,Kramer GM,Frings V,et al.Repeatability of radiomic features in Non-Small-Cell lung cancer[18F]FDG-PET/CT Studies:impact of reconstruction and delineation[J].Mol Imaging Biol,2016,18(5):788-795.
31 Zhao B,Tan Y,Tsai W,et al.Reproducibility of radiomics for deciphering tumor phenotype with imaging[J].Sci Rep,2016,6:23428.

[1]	王俊美, 潘慧卿, 李婧铱, 贾迪, 赵炜明, 吕昌莲. MT2-MMP在Ⅱ期肺腺癌中的表达及临床意义[J]. 实用肿瘤学杂志, 2021, 35(3): 243-247.
[2]	尹蕾, 杨旭东, 杨悦, 牛星鉴, 周晓平, 姬宏飞, 王一然. 中性粒细胞与淋巴细胞比值在非小细胞肺癌患者预后评估中的临床意义及相关机制研究[J]. 实用肿瘤学杂志, 2021, 35(2): 117-124.
[3]	董程(综述),段勇(审校). Dickkopf家族蛋白在非小细胞肺癌中的作用机制和治疗应用的研究进展[J]. 实用肿瘤学杂志, 2021, 35(1): 64-68.
[4]	闫䶮, 侯利芳, 李任飞, 闫鹏, 王月东, 郑玉婷. ^99mTc-HYNIC-MPG在体非小细胞肺癌分子分型研究[J]. 实用肿瘤学杂志, 2020, 34(5): 412-417.
[5]	孙亚娟, 姜智允, 尚乃舰, 孙庆鑫, 陆佩欧. 双源CT能量成像在评估非小细胞肺癌纵隔淋巴结转移中的应用价值[J]. 实用肿瘤学杂志, 2019, 33(6): 531-535.
[6]	孙立春,李丹丹,李净,于凤玲. CCDC8和TGF-β1在非小细胞肺癌中的表达及临床意义[J]. 实用肿瘤学杂志, 2019, 33(3): 215-221.
[7]	李万祯, 殷俊, 李萍, 林晓辉, 张国前, 张书旭. iR-17在非小细胞肺癌放射抗拒细胞中的表达及作用研究[J]. 实用肿瘤学杂志, 2018, 32(5): 391-397.
[8]	蔡静, 候玥. 非小细胞肺癌患者血清miR-195的表达及其临床意义[J]. 实用肿瘤学杂志, 2018, 32(5): 415-419.
[9]	崔晓燕, 涂青, 甘建辉. 纳布啡与羟考酮自控镇痛对非小细胞肺癌患者术后免疫因子水平影响的比较[J]. 实用肿瘤学杂志, 2018, 32(4): 309-314.
[10]	雷俊华, 许冠华, 曾江正, 黄芬, 何志惠, 卢彦达. 隐丹参酮联合顺铂抗非小细胞肺癌NCI-H1975细胞JAK2/STAT3机制研究[J]. 实用肿瘤学杂志, 2018, 32(3): 198-202.
[11]	翟可可, 高媛媛, 冯晓, 许静文, 宫玉芳, 孟庆威. 术后辅助化疗后复发转移与初次诊断的IV期NSCLC一线化疗疗效分析[J]. 实用肿瘤学杂志, 2018, 32(2): 107-111.
[12]	杜夜生, 胡松柳, 徐向英. 非小细胞肺癌寡转移的立体定向放射治疗研究[J]. 实用肿瘤学杂志, 2018, 32(2): 154-158.
[13]	孙明亮, 徐建宇, 徐向英. 早期非小细胞肺癌立体定向放疗的相关研究[J]. 实用肿瘤学杂志, 2018, 32(1): 53-56.
[14]	代欣综述, 张大昕审校. 非小细胞肺癌抗血管生成治疗研究现状[J]. 实用肿瘤学杂志, 2017, 31(5): 472-476.
[15]	胡海峰, 冯谢敏, 乔健, 段伟, 刘宁宁, 孙晓东. miR-345在非小细胞肺癌中的表达及临床意义[J]. 实用肿瘤学杂志, 2017, 31(2): 117-122.